Hsing-Wu Chen

Years Active: 2021-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Hsing-Wu Chen, Yao-Wen Kuo, Chung-Yu Chen, Chin-Hao Chang, Su-Mei Wang, Ying-Chun Chien, Wei-Chen Lu, Jo-Pai Chen, Cheng-Yu Chang, Yu-Feng Wei, Shih-Chieh Chang, Chin-Chung Shu, Jann-Yuan Wang, Wei-Yu Liao, Hao-Chien Wang, Chong-Jen Yu
Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy. The oncologist 29 (4) (2024)
Hsing-Wu Chen, Yao-Wen Kuo, Chung-Yu Chen, Chin-Hao Chang, Su-Mei Wang, Ying-Chun Chien, Wei-Chen Lu, Jo-Pai Chen, Cheng-Yu Chang, Yu-Feng Wei, Shih-Chieh Chang, Chin-Chung Shu, Jann-Yuan Wang, Wei-Yu Liao, Hao-Chien Wang, Chong-Jen Yu
Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy. The oncologist 29 (4) (2024)
Hsing-Wu Chen, Yao-Wen Kuo, Chung-Yu Chen, Chin-Hao Chang, Su-Mei Wang, Ying-Chun Chien, Wei-Chen Lu, Jo-Pai Chen, Cheng-Yu Chang, Yu-Feng Wei, Shih-Chieh Chang, Chin-Chung Shu, Jann-Yuan Wang, Wei-Yu Liao, Hao-Chien Wang, Chong-Jen Yu
Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy. The oncologist (2024)
Hsing-Wu Chen, Tom Wei-Wu Chen
Revisiting Adjuvant Hormone Therapy in Premenopausal Women With Breast Cancer: Escalation and De-Escalation. JCO oncology practice (2021)

Hsing-Wu Chen.css-eqlu8i{font-size:small;padding-left:4px;}